Brivanib Alaninate (BMS-582664) is the alaninate salt of a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells, inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression.
Molecular Weight:
441.46
Purity:
99.66%
CAS Number:
[649735-63-7]
Formula:
C22H24FN5O4
Target:
FGFR|||VEGFR|||Autophagy
T2576
* VAT and and shipping costs not included. Errors and price changes excepted
